FDA Cancer Czar Floats Change to Drug Review Process

Scientific AmericanFDA Cancer Czar Floats Change to Drug Review ProcessScientific AmericanScientists now know that what matters most in determining the behavior of a particular cancer (and its response to specific therapy) are the molecular pathways that drive malignant cell growth instead of where the tumor begins in the body. A tumor in ...

Share this post